INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42m ago
HOUSE PTR2m ago
SEC 13F1m ago
ROBINHOOD CHAIN1m ago
Public company

ZVRAZEVRA THERAPEUTICS, INC.

CIK 0001434647

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells0 / 3
Max Insider Score18
Connections3with evidence

ZVRA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$97K
10.5K sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 5, 2026
  • ← Insider ofevidence
    Schafer JoshuaCCO · Feb 2, 2026
  • ← Insider ofevidence
    Quartel Adrian WChief Medical Officer · Feb 2, 2026
7
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M
—
11.3K sh
Jan 30, 2026
Feb 2, 2026
traded Jan 30, 2026
+3d
SEC FORM 4

Evidence

14
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$30K
3,375 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

7
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
35.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence

0
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
37.5K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

0
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
75.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

11
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

0
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
35.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence

11
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

18
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$40K
4,533 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

0
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
37.5K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

0
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
75.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC FORM 4

Evidence

11
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence